Torno Capital, LLC Ultragenyx Pharmaceutical Inc. Call Options Transaction History

Torno Capital, LLC

  • $624 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$40.21 - $59.36 $1.21 Million - $1.78 Million
30,000 New
30,000 $1.67 Billion
Q1 2024

May 15, 2024
SELL
$43.02 - $53.69 $1.07 Million - $1.34 Million
-24,900 Reduced 99.6%
100 $4.67 Million
Q4 2023

Feb 14, 2024
BUY
$31.73 - $49.19 $793,250 - $1.23 Million
25,000 New
25,000 $1.2 Billion

Others Institutions Holding RARE

# of Institutions
326
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.15B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Torno Capital, LLC Portfolio

Follow Torno Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torno Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email